Skip to main content

Melanoma and Spitz Nevi in Children

  • Chapter
  • First Online:
Skin Tumors and Reactions to Cancer Therapy in Children

Abstract

Children commonly develop new nevi over time, and existing nevi can evolve. Determining which new or changing nevi are concerning for melanoma is a unique challenge in the pediatric population. Pediatric melanoma is uncommon and accounts for about 6% of cancers in adolescents. The incidence of melanoma in individuals under 20 years of age is 0.37 per 100,000 person years. Although rare, timely diagnosis and treatment is essential. Spitz nevi, originally named “benign juvenile melanoma,” are most common in the pediatric population and can have clinical and histologic features that are concerning for melanoma. Atypical Spitz tumors straddle Spitz nevi and melanoma, with atypical features that approach, but do not meet criteria for melanoma. Distinguishing between Spitz nevi, atypical Spitz tumors, and melanoma can be difficult. This chapter reviews the clinical, histologic, and genetic characteristics of these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C. Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer. 2003;97(3):628–38.

    Article  PubMed  CAS  Google Scholar 

  2. Harrison SL, MacKie RM, MacLennan R. Development of melanocytic nevi in the first three years of life. J Natl Cancer Inst. 2000;92(17):1436–8.

    Article  CAS  PubMed  Google Scholar 

  3. Scope A, Dusza SW, Marghoob AA, Satagopan JM, Braga Casagrande Tavoloni J, Psaty EL, et al. Clinical and dermoscopic stability and volatility of melanocytic nevi in a population-based cohort of children in Framingham school system. J Invest Dermatol. 2011;131(8):1615–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Pizzichetta MA, Talamini R, Stanganelli I, Soyer HP. Natural history of atypical and equivocal melanocytic lesions in children: an observational study of 19 cases. Pediatr Dermatol. 2014;31(3):331–6.

    Article  PubMed  Google Scholar 

  5. Siskind V, Darlington S, Green L, Green A. Evolution of melanocytic nevi on the faces and necks of adolescents: a 4 y longitudinal study. J Invest Dermatol. 2002;118(3):500–4.

    Article  CAS  PubMed  Google Scholar 

  6. Spitz S. Melanomas of childhood. Am J Pathol. 1948;24(3):591–609.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Dal Pozzo V, Benelli C, Restano L, Gianotti R, Cesana BM. Clinical review of 247 case records of Spitz nevus (epithelioid cell and/or spindle cell nevus). Dermatol Basel Switz. 1997;194(1):20–5.

    Article  CAS  Google Scholar 

  8. Lott JP, Wititsuwannakul J, Lee JJ, Ariyan S, Narayan D, Kluger HH, et al. Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: the Yale University Spitzoid neoplasm repository experience, 1991 to 2008. J Am Acad Dermatol. 2014;71(6):1077–82.

    Article  PubMed  Google Scholar 

  9. Weedon D, Little JH. Spindle and epithelioid cell nevi in children and adults. A review of 211 cases of the Spitz nevus. Cancer. 1977;40(1):217–25.

    Article  CAS  PubMed  Google Scholar 

  10. Pedrosa AF, Lopes JM, Azevedo F, Mota A. Spitz/Reed nevi: a review of clinical-dermatoscopic and histological correlation. Dermatol Pract Concept. 2016;6(2):37–41.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Requena C, Requena L, Kutzner H, Sánchez YE. Spitz nevus: a clinicopathological study of 349 cases. Am J Dermatopathol. 2009;31(2):107–16.

    Article  PubMed  Google Scholar 

  12. Berlingeri-Ramos AC, Morales-Burgos A, Sánchez JL, Nogales EM. Spitz nevus in a Hispanic population: a clinicopathological study of 130 cases. Am J Dermatopathol. 2010;32(3):267–75.

    PubMed  Google Scholar 

  13. Argenziano G, Zalaudek I, Ferrara G, Lorenzoni A, Soyer HP. Involution: the natural evolution of pigmented Spitz and reed nevi? Arch Dermatol. 2007;143(4):549–51.

    Article  PubMed  Google Scholar 

  14. Colucci R, Berruti V, Moretti S. Pediatric pigmented Spitz nevus: a natural course toward involution assessed with dermoscopy. J Am Acad Dermatol. 2016;75(2):e61–2.

    Article  PubMed  Google Scholar 

  15. Sau P, Graham JH, Helwig EB. Pigmented spindle cell nevus: a clinicopathologic analysis of ninety-five cases. J Am Acad Dermatol. 1993;28(4):565–71.

    Article  CAS  PubMed  Google Scholar 

  16. Luo S, Sepehr A, Tsao H. Spitz nevi and other Spitzoid lesions: part I. Background and diagnoses. J Am Acad Dermatol. 2011;65(6):1073–84.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kerner M, Jaimes N, Scope A, Marghoob AA. Spitz nevi: a bridge between dermoscopic morphology and histopathology. Dermatol Clin. 2013;31(2):327–35.

    Article  CAS  PubMed  Google Scholar 

  18. Ferrara G, Argenziano G, Soyer HP, Chimenti S, Di Blasi A, Pellacani G, et al. The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol. 2005;141(11):1381–7.

    Article  PubMed  Google Scholar 

  19. Argenziano G, Agozzino M, Bonifazi E, Broganelli P, Brunetti B, Ferrara G, et al. Natural evolution of Spitz nevi. Dermatol Basel Switz. 2011;222(3):256–60.

    Article  Google Scholar 

  20. Marchell R, Marghoob AA, Braun RP, Argenziano G. Dermoscopy of pigmented Spitz and reed nevi: the starburst pattern. Arch Dermatol. 2005;141(8):1060.

    Article  PubMed  Google Scholar 

  21. Bastian BC, Wesselmann U, Pinkel D, Leboit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999;113(6):1065–9.

    Article  CAS  PubMed  Google Scholar 

  22. Nino M, Brunetti B, Delfino S, Brunetti B, Panariello L, Russo D. Spitz nevus: follow-up study of 8 cases of childhood starburst type and proposal for management. Dermatol Basel Switz. 2009;218(1):48–51.

    Article  Google Scholar 

  23. Brunetti B, Nino M, Sammarco E, Scalvenzi M. Spitz naevus: a proposal for management. J Eur Acad Dermatol Venereol. 2005;19(3):391–3.

    Article  CAS  PubMed  Google Scholar 

  24. Zedek DC, McCalmont TH. Spitz nevi, atypical spitzoid neoplasms, and spitzoid melanoma. Clin Lab Med. 2011;31(2):311–20.

    Article  PubMed  Google Scholar 

  25. Ferrara G, Zalaudek I, Savarese I, Scalvenzi M, Argenziano G. Pediatric atypical spitzoid neoplasms: a review with emphasis on “red” (‘spitz’) tumors and “blue” (‘blitz’) tumors. Dermatol Basel Switz. 2010;220(4):306–10.

    Article  Google Scholar 

  26. Joyce DP, Prichard RS, Gulmann C, Hill ADK. The surgical management of Spitz naevi and atypical spitzoid neoplasms: a review of the literature. Surg J R Coll Surg Edinb Irel. 2013;11(4):205–9.

    CAS  Google Scholar 

  27. Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, “Spitzoid melanoma” and risk assessment. Mod Pathol. 2006;19(Suppl 2):S21–33.

    Article  PubMed  Google Scholar 

  28. Gelbard SN, Tripp JM, Marghoob AA, Kopf AW, Koenig KL, Kim JY, et al. Management of Spitz nevi: a survey of dermatologists in the United States. J Am Acad Dermatol. 2002;47(2):224–30.

    Article  PubMed  Google Scholar 

  29. Casso EM, Grin-Jorgensen CM, Grant-Kels JM. Spitz nevi. J Am Acad Dermatol. 1992;27(6 Pt 1):901–13.

    Article  CAS  PubMed  Google Scholar 

  30. Tlougan BE, Orlow SJ, Schaffer JV. Spitz nevi: beliefs, behaviors, and experiences of pediatric dermatologists. JAMA Dermatol. 2013;149(3):283–91.

    Article  PubMed  Google Scholar 

  31. Elder DE, Xu X. The approach to the patient with a difficult melanocytic lesion. Pathology (Phila). 2004;36(5):428–34.

    Google Scholar 

  32. Moscarella E, Lallas A, Kyrgidis A. Clinical and dermoscopic features of atypical Spitz tumors: a multi-center, retrospective, case-control study. JAAD. 2015;73(5):777–84.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Gill M, Cohen J, Renwick N, Mones JM, Silvers DN, Celebi JT. Genetic similarities between Spitz nevus and Spitzoid melanoma in children. Cancer. 2004;101(11):2636–40.

    Article  PubMed  Google Scholar 

  34. Van Dijk MCRF, Bernsen MR, Ruiter DJ. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. Am J Surg Pathol. 2005;29(9):1145–51.

    Article  PubMed  Google Scholar 

  35. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000;157(3):967–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Da Forno PD, Pringle JH, Fletcher A, Bamford M, Su L, Potter L, et al. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance. Br J Dermatol. 2009;161(2):364–72.

    Article  PubMed  CAS  Google Scholar 

  37. Van Engen-van Grunsven ACH, van Dijk MCRF, Ruiter DJ, Klaasen A, Mooi WJ, Blokx WAM. HRAS-mutated Spitz tumors: a subtype of Spitz tumors with distinct features. Am J Surg Pathol. 2010;34(10):1436–41.

    Article  PubMed  Google Scholar 

  38. Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, et al. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol. 2012;36(6):818–30.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wiesner T, Kutzner H, Cerroni L, Mihm MC, Busam KJ, Murali R. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy. Pathology (Phila). 2016;48(2):113–31.

    CAS  Google Scholar 

  40. Yeh I, Botton T, Talevich E, Shain AH, Sparatta AJ, de la Fouchardiere A, et al. Activating MET kinase rearrangements in melanoma and Spitz tumours. Nat Commun. 2015;6:7174.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Wiesner T, He J, Yelensky R, Esteve-Puig R, Botton T, Yeh I, et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun. 2014;5:3116.

    PubMed  PubMed Central  Google Scholar 

  42. Yeh I, de la Fouchardiere A, Pissaloux D, Mully TW, Garrido MC, Vemula SS, et al. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions. Am J Surg Pathol. 2015;39(5):581–91.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Busam KJ, Kutzner H, Cerroni L, Wiesner T. Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions. Am J Surg Pathol. 2014;38(7):925–33.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Yazdan P, Cooper C, Sholl LM, Busam K, Rademaker A, Weitner BB, et al. Comparative analysis of atypical spitz tumors with heterozygous versus homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression. Am J Surg Pathol. 2014;38(5):638–45.

    Article  PubMed  Google Scholar 

  45. Gerami P, Busam K, Cochran A, Cook MG, Duncan LM, Elder DE, et al. Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up. Am J Surg Pathol. 2014;38(7):934–40.

    Article  PubMed  Google Scholar 

  46. Tom WL, Hsu JW, Eichenfield LF, Friedlander SF. Pediatric “STUMP” lesions: evaluation and management of difficult atypical Spitzoid lesions in children. J Am Acad Dermatol. 2011;64(3):559–72.

    Article  PubMed  Google Scholar 

  47. Bergman R, Malkin L, Sabo E, Kerner H. MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi. J Am Acad Dermatol. 2001;44(3):500–4.

    Article  CAS  PubMed  Google Scholar 

  48. Gerami P, Scolyer RA, Xu X, Elder DE, Abraham RM, Fullen D, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol. 2013;37(5):676–84.

    Google Scholar 

  49. Gerami P, Cooper C, Bajaj S, Wagner A, Fullen D, Busam K, et al. Outcomes of atypical spitz tumors with chromosomal copy number aberrations and conventional melanomas in children. Am J Surg Pathol. 2013;37(9):1387–94.

    Article  PubMed  Google Scholar 

  50. Lee CY, Sholl LM, Zhang B, Merkel EA, Amin SM, Guitart J, et al. Atypical Spitzoid neoplasms in childhood: a molecular and outcome study. Am J Dermatopathol. 2017;39(3):181–6.

    Article  PubMed  Google Scholar 

  51. Gammon B, Beilfuss B, Guitart J, Gerami P. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe. Am J Surg Pathol. 2012;36(1):81–8.

    Article  PubMed  Google Scholar 

  52. Gerami P, Li G, Pouryazdanparast P, Blondin B, Beilfuss B, Slenk C, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol. 2012;36(6):808–17.

    Google Scholar 

  53. Shen L, Cooper C, Bajaj S, Liu P, Pestova E, Guitart J, et al. Atypical spitz tumors with 6q23 deletions: a clinical, histological, and molecular study. Am J Dermatopathol. 2013;35(8):804–12.

    Article  PubMed  Google Scholar 

  54. Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003;163(5):1765–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Bastian BC, LeBoit PE, Hamm H, Bröcker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 1998;58(10):2170–5.

    CAS  PubMed  Google Scholar 

  56. Biddle DA, Evans HL, Kemp BL, El-Naggar AK, Harvell JD, White WL, et al. Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma. Am J Surg Pathol. 2003;27(5):673–81.

    Article  PubMed  Google Scholar 

  57. Murali R, Sharma RN, Thompson JF, Stretch JR, Lee CS, McCarthy SW, et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Ann Surg Oncol. 2008;15(1):302–9.

    Article  PubMed  Google Scholar 

  58. Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol. 2002;26(1):47–55.

    Article  PubMed  Google Scholar 

  59. Urso C. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer. 2010;116(1):258; author reply 258–259

    PubMed  Google Scholar 

  60. Su LD, Fullen DR, Sondak VK, Johnson TM, Lowe L. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Cancer. 2003;97(2):499–507.

    Article  PubMed  Google Scholar 

  61. Hung T, Piris A, Lobo A, Mihm MC, Sober AJ, Tsao H, et al. Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors. Hum Pathol. 2013;44(1):87–94.

    Article  PubMed  Google Scholar 

  62. Sepehr A, Chao E, Trefrey B, Blackford A, Duncan LM, Flotte TJ, et al. Long-term outcome of Spitz-type melanocytic tumors. Arch Dermatol. 2011;147(10):1173–9.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Busam KJ, Murali R, Pulitzer M, McCarthy SW, Thompson JF, Shaw HM, et al. Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas. Am J Surg Pathol. 2009;33(9):1386–95.

    Article  PubMed  Google Scholar 

  64. Ghazi B, Carlson GW, Murray DR, Gow KW, Page A, Durham M, et al. Utility of lymph node assessment for atypical Spitzoid melanocytic neoplasms. Ann Surg Oncol. 2010;17(9):2471–5.

    Article  PubMed  Google Scholar 

  65. Cerrato F, Wallins JS, Webb ML, McCarty ER, Schmidt BA, Labow BI. Outcomes in pediatric atypical Spitz tumors treated without sentinel lymph node biopsy: outcomes in pediatric atypical Spitz tumors. Pediatr Dermatol. 2012;29(4):448–53.

    Article  PubMed  Google Scholar 

  66. Lallas A, Kyrgidis A, Ferrara G, Kittler H, Apalla Z, Castagnetti F, et al. Atypical Spitz tumours and sentinel lymph node biopsy: a systematic review. Lancet Oncol. 2014;15(4):e178–83.

    Article  PubMed  Google Scholar 

  67. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER cancer statistics review, 1975-2013. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016.

  68. Siegel DA, King J, Tai E, Buchanan N, Ajani UA, Li J. Cancer incidence rates and trends among children and adolescents in the United States, 2001-2009. Pediatrics. 2014;134(4):e945–55.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Campbell LB, Kreicher KL, Gittleman HR, Strodtbeck K, Barnholtz-Sloan J, Bordeaux JS. Melanoma incidence in children and adolescents: decreasing trends in the United States. J Pediatr. 2015;166(6):1505–13.

    Article  PubMed  Google Scholar 

  70. Barr RD, Ries LAG, Lewis DR, Harlan LC, Keegan THM, Pollock BH, et al. Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including “nonmalignant/noninvasive” tumors: adolescent young adult cancer incidence. Cancer. 2016;122(7):1000–8.

    Article  PubMed  Google Scholar 

  71. Baade PD, Green AC, Smithers BM, Aitken JF. Trends in melanoma incidence among children: possible influence of sun-protection programs. Expert Rev Anticancer Ther. 2011;11(5):661–4.

    Article  PubMed  Google Scholar 

  72. Richardson SK, Tannous ZS, Mihm MC. Congenital and infantile melanoma: review of the literature and report of an uncommon variant, pigment-synthesizing melanoma. J Am Acad Dermatol. 2002;47(1):77–90.

    Article  PubMed  Google Scholar 

  73. Cordoro KM, Gupta D, Frieden IJ, McCalmont T, Kashani-Sabet M. Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children. J Am Acad Dermatol. 2013;68(6):913–25.

    Article  PubMed  Google Scholar 

  74. Averbook BJ, Lee SJ, Delman KA, Gow KW, Zager JS, Sondak VK, et al. Pediatric melanoma: analysis of an international registry. Cancer. 2013;119(22):4012–9.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Dawson HA, Atherton DJ, Mayou B. A prospective study of congenital melanocytic naevi: progress report and evaluation after 6 years. Br J Dermatol. 1996;134(4):617–23.

    Article  CAS  PubMed  Google Scholar 

  76. Kinsler VA, Birley J, Atherton DJ. Great Ormond Street Hospital for Children registry for congenital melanocytic naevi: prospective study 1988-2007. Part 1-epidemiology, phenotype and outcomes. Br J Dermatol. 2009;160(1):143–50.

    Article  CAS  PubMed  Google Scholar 

  77. Swerdlow AJ, English JS, Qiao Z. The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol. 1995;32(4):595–9.

    Article  CAS  PubMed  Google Scholar 

  78. Tannous ZS, Mihm MC, Sober AJ, Duncan LM. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol. 2005;52(2):197–203.

    Article  PubMed  Google Scholar 

  79. Sahin S, Levin L, Kopf AW, Rao BK, Triola M, Koenig K, et al. Risk of melanoma in medium-sized congenital melanocytic nevi: a follow-up study. J Am Acad Dermatol. 1998;39(3):428–33.

    Article  CAS  PubMed  Google Scholar 

  80. Scalzo DA, Hida CA, Toth G, Sober AJ, Mihm MC. Childhood melanoma: a clinicopathological study of 22 cases. Melanoma Res. 1997;7(1):63–8.

    Article  CAS  PubMed  Google Scholar 

  81. Zaal LH, Mooi WJ, Klip H, van der Horst CMAM. Risk of malignant transformation of congenital melanocytic nevi: a retrospective nationwide study from The Netherlands. Plast Reconstr Surg. 2005;116(7):1902–9.

    Article  CAS  PubMed  Google Scholar 

  82. Bett BJ. Large or multiple congenital melanocytic nevi: occurrence of cutaneous melanoma in 1008 persons. J Am Acad Dermatol. 2005;52(5):793–7.

    Article  PubMed  Google Scholar 

  83. Bittencourt FV, Marghoob AA, Kopf AW, Koenig KL, Bart RS. Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics. 2000;106(4):736–41.

    Article  CAS  PubMed  Google Scholar 

  84. DeDavid M, Orlow SJ, Provost N, Marghoob AA, Rao BK, Huang CL, et al. A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University registry and the world literature. J Am Acad Dermatol. 1997;36(3 Pt 1):409–16.

    Article  CAS  PubMed  Google Scholar 

  85. Ruiz-Maldonado R, Tamayo L, Laterza AM, Durán C. Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr. 1992;120(6):906–11.

    Article  CAS  PubMed  Google Scholar 

  86. Egan CL, Oliveria SA, Elenitsas R, Hanson J, Halpern AC. Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients. J Am Acad Dermatol. 1998;39(6):923–32.

    Article  CAS  PubMed  Google Scholar 

  87. Chan Y-C, Giam Y-C. A retrospective cohort study of Southeast Asian patients with large congenital melanocytic nevi and the risk of melanoma development. J Am Acad Dermatol. 2006;54(5):778–82.

    Article  PubMed  Google Scholar 

  88. Hale EK, Stein J, Ben-Porat L, Panageas KS, Eichenbaum MS, Marghoob AA, et al. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi--results from the NYU-LCMN registry. Br J Dermatol. 2005;152(3):512–7.

    Article  CAS  PubMed  Google Scholar 

  89. Ka VSK, Dusza SW, Halpern AC, Marghoob AA. The association between large congenital melanocytic naevi and cutaneous melanoma: preliminary findings from an internet-based registry of 379 patients. Melanoma Res. 2005;15(1):61–7.

    Article  PubMed  Google Scholar 

  90. Watt AJ, Kotsis SV, Chung KC. Risk of melanoma arising in large congenital melanocytic nevi: a systematic review. Plast Reconstr Surg. 2004;113(7):1968–74.

    Article  PubMed  Google Scholar 

  91. Krengel S, Hauschild A, Schäfer T. Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol. 2006;155(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  92. Vourc’h-Jourdain M, Martin L, Barbarot S. Large congenital melanocytic nevi: therapeutic management and melanoma risk. J Am Acad Dermatol. 2013;68(3):493–498.e14.

    Article  PubMed  Google Scholar 

  93. Coughlin CC, Council ML, Gru AA, Fields RC, Bayliss SJ. Malignant melanoma arising at the site of a previously excised giant congenital melanocytic nevus. JAMA Dermatol. 2014;150(1):100–1.

    Article  PubMed  Google Scholar 

  94. Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H. Hereditary melanoma: update on syndromes and management: genetics of familial atypical multiple mole melanoma syndrome. J Am Acad Dermatol. 2016;74(3):395–407; quiz 408–410

    Article  PubMed  PubMed Central  Google Scholar 

  95. Brenn T, McKee PH. Melanoma in children and adolescents. Diagn Histopathol. 2008;14(1):18–27.

    Article  Google Scholar 

  96. Lu C, Zhang J, Nagahawatte P, Easton J, Lee S, Liu Z, et al. The genomic landscape of childhood and adolescent melanoma. J Invest Dermatol. 2015;135(3):816–23.

    Article  CAS  PubMed  Google Scholar 

  97. Menzies AM, Haydu LE, Visintin L, Carlino MS, Howle JR, Thompson JF, et al. Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma. Clin Cancer Res. 2012;18(12):3242–9.

    Article  CAS  PubMed  Google Scholar 

  98. Griewank KG, Murali R, Puig-Butille JA, Schilling B, Livingstone E, Potrony M, et al. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma. J Natl Cancer Inst. 2014;106(9)

    Google Scholar 

  99. Balch CM, Gershenwald JE, Soong S-J, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206.

    Article  PubMed  PubMed Central  Google Scholar 

  100. French JC, Rowe MR, Lee TJO, Zwart JE. Pediatric melanoma of the head and neck: a single institutions experience. Laryngoscope. 2006;116(12):2216–20.

    Article  PubMed  Google Scholar 

  101. Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE, et al. Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14(4):450–73.

    Article  Google Scholar 

  102. Paradela S, Fonseca E, Pita-Fernández S, Kantrow SM, Diwan AH, Herzog C, et al. Prognostic factors for melanoma in children and adolescents: a clinicopathologic, single-center study of 137 patients. Cancer. 2010;116(18):4334–44.

    Article  PubMed  Google Scholar 

  103. Howman-Giles R, Shaw HM, Scolyer RA, Murali R, Wilmott J, McCarthy SW, et al. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients. Ann Surg Oncol. 2010;17(1):138–43.

    Article  PubMed  Google Scholar 

  104. Kim J, Sun Z, Gulack BC, Adam MA, Mosca PJ, Rice HE, et al. Sentinel lymph node biopsy is a prognostic measure in pediatric melanoma. J Pediatr Surg. 2016;51(6):986–90.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Moore-Olufemi S, Herzog C, Warneke C, Gershenwald JE, Mansfield P, Ross M, et al. Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients. Ann Surg. 2011;253(6):1211–5.

    Article  PubMed  Google Scholar 

  106. Lorimer PD, White RL, Walsh K, Han Y, Kirks RC, Symanowski J, et al. Pediatric and adolescent melanoma: a National Cancer Data Base Update. Ann Surg Oncol. 2016;23(12):4058–66.

    Article  PubMed  Google Scholar 

  107. Mills O, Messina JL. Pediatric melanoma: a review. Cancer Control J Moffitt Cancer Cent. 2009;16(3):225–33.

    Article  Google Scholar 

  108. Roaten JB, Partrick DA, Bensard D, Pearlman N, Gonzalez R, Fitzpatrick J, et al. Survival in sentinel lymph node-positive pediatric melanoma. J Pediatr Surg. 2005;40(6):988–92; discussion 992

    Article  PubMed  Google Scholar 

  109. Prieto VG, Clark SH. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol. 2002;6(4):257–64.

    Article  PubMed  Google Scholar 

  110. Mu E, Lange JR, Strouse JJ. Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma. Cancer. 2012;118(10):2700–7.

    Article  PubMed  Google Scholar 

  111. Ra JH, McMasters KM, Spitz FR. Should all melanoma patients undergo sentinel lymph node biopsy? Curr Opin Oncol. 2006;18(2):185–8.

    Article  PubMed  Google Scholar 

  112. Huynh KT, Takei Y, Kuo C, Scolyer RA, Murali R, Chong K, et al. Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma. Br J Dermatol. 2012;166(6):1319–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Topar G, Zelger B. Assessment of value of the sentinel lymph node biopsy in melanoma in children and adolescents and applicability of subcutaneous infusion anesthesia. J Pediatr Surg. 2007;42(10):1716–20.

    Article  PubMed  Google Scholar 

  114. Chao MM, Schwartz JL, Wechsler DS, Thornburg CD, Griffith KA, Williams JA. High-risk surgically resected pediatric melanoma and adjuvant interferon therapy. Pediatr Blood Cancer. 2005;44(5):441–8.

    Article  PubMed  Google Scholar 

  115. Lewis KG. Trends in pediatric melanoma mortality in the United States, 1968 through 2004: trends in pediatric melanoma mortality. Dermatol Surg. 2007;34(2):152–9.

    Article  PubMed  CAS  Google Scholar 

  116. Lange JR, Palis BE, Chang DC, Soong S-J, Balch CM. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J Clin Oncol. 2007;25(11):1363–8.

    Article  PubMed  Google Scholar 

  117. Ferrari A, Bono A, Baldi M, Collini P, Casanova M, Pennacchioli E, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005;115(3):649–54.

    Article  PubMed  Google Scholar 

  118. Pol-Rodriquez M, Lee S, Silvers DN, Celebi JT. Influence of age on survival in childhood spitzoid melanomas. Cancer. 2007;109(8):1579–83.

    Article  PubMed  Google Scholar 

  119. Paradela S, Fonseca E, Pita-Fernández S, Prieto VG. Spitzoid and non-spitzoid melanoma in children: a prognostic comparative study. J Eur Acad Dermatol Venereol. 2013;27(10):1214–21.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Melinda Jen M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Warner, C., Jen, M. (2018). Melanoma and Spitz Nevi in Children. In: Huang, J., Coughlin, C. (eds) Skin Tumors and Reactions to Cancer Therapy in Children. Springer, Cham. https://doi.org/10.1007/978-3-319-66200-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66200-8_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66199-5

  • Online ISBN: 978-3-319-66200-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics